Clinical Trial Update: Evaluating the Efficacy and Safety of of HSK44459 in People With Progressive Pulmonary Fibrosis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the efficacy and safety of HSK44459 for progressive pulmonary fibrosis; the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Fibrosis

Drugs mentioned

• HSK44459

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Progressive Pulmonary Fibrosis | Phase 3 | Status: NOT_YET_RECRUITING